1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6FFD2C8D5B69C723885256E4500770EC8
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/market-research-for-pharmaceutical-launches?opendocument
18
19opendocument
203.237.15.145
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Market Research, Analytics and Forecasting » Market Research Structure

Market Research for Pharmaceutical Launches

DB Image

ID: 4571


Features:

Detailed Process Map


Pages/Slides: 17


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
As the market for pharmaceutical products grows, top-performing pharmaceutical companies must involve marketing as early as possible to achieve worldwide appeal.

This 17-page document describes how pharmaceutical companies can launch products with greater market and consumer appeal, greater speed to market and greater sales potential for the life of the product.

Pharmaceutical companies can use this information to constitute an integrated system for new product development and marketing.

Key topics covered in this document include:
- Product Marketing and Management
- Global Distribution of Market Knowledge
- Market Research Funding and Staffing

Select best practices include:
1. Analyze pre-clinical and ongoing market research to achieve resource optimization and better speed to market.
- Several benchmarking partners conduct market forecasting to prioritize products or compounds for resource allocation as far back as seven to ten years before launch – before clinical trials begin.
2. Utilize modeling or scenario techniques to predict new product success.
- One benchmark partner models artificial markets to predict the level of success of a particular drug in order to gain insight about particular markets.
3. Integrate market research with the design of clinical trials to identify market need gaps and fine-tune product positioning.
- One interviewed executive identified the single most important determinant of a product’s launch success: its positioning relative to competing products in the same therapeutic area.

This research originated from a Best Practices, LLC consulting project.

Industries Profiled:
Pharmaceutical; Health Care; Biotech; Medical Device


Companies Profiled:
Sanofi-aventis; Merck; Eli Lilly; GlaxoSmithKline; Novartis; Pfizer; Johnson & Johnson; Bristol-Myers Squibb; AstraZeneca; Roche; Schering-Plough

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.